Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-05-02 @ 7:35 PM
Study NCT ID:
NCT01122251
Status:
COMPLETED
Last Update Posted:
2011-02-18
First Post:
2010-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension
Sponsor:
LG Life Sciences
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LG-ZVCL001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Kim, Sung Il / Assistant Manager
Old Organization:
Clinical Trial 1 Team